中国癌症杂志 ›› 2018, Vol. 28 ›› Issue (1): 22-29.doi: 10.19401/j.cnki.1007-3639.2018.01.003

• 论著 • 上一篇    下一篇

LncRNA RP11-79H23.3在膀胱癌细胞中的作用及其发生、发展的研究

池 虹,陈俊霞   

  1. 重庆医科大学细胞生物学与遗传学教研室,重庆 400016
  • 出版日期:2018-01-30 发布日期:2018-02-07
  • 通信作者: 陈俊霞 E-mail:chjunxia@126.com

The role of lncRNA RP11-79H23.3 in bladder cancer cells and its mechanism

CHI Hong, CHEN Junxia   

  1. Department of Cell Biology and Genetics, Chongqing Medical University, Chongqing 400016, China
  • Published:2018-01-30 Online:2018-02-07
  • Contact: CHEN Junxia E-mail: chjunxia@126.com

摘要:

背景与目的:虽然许多长链非编码RNA(long non-coding RNA,lncRNA)的异常表达与膀胱癌的发生有密切关系,但对于lncRNA RP11-79H23.3暂未见报道。该研究旨在探讨lncRNA RP11-79H23.3在膀胱癌EJ细胞中的作用及其发生、发展的机制。方法:采用微阵列方法对4对膀胱癌患者的癌和癌旁组织进行组学分析,随后用实时荧光定量聚合酶链反应(real-time fluorescent quantitative polymerase chain reaction,RTFQ-PCR)检测膀胱癌组织、癌旁组织及正常人膀胱上皮细胞sv-HUC-1、膀胱癌EJ细胞中RP11-79H23.3的表达。通过转染pIRES2-RP11-79H23.3上调该基因后,采用细胞计数试剂盒(cell counting kit-8,CCK-8)和EdU的方法检测EJ细胞的增殖活性,通过Transwell小室和平板划痕实验分别检测EJ细胞的侵袭和迁移能力,应用流式细胞术、Hoechst33342及Tunel检测细胞凋亡,应用细胞免疫荧光检测PTEN在膀胱癌细胞中的定位,采用鬼笔环肽染色观察细胞骨架形成,应用蛋白[质]印迹法(Western blot)分析过表达RP11-79H23.3后EJ细胞中PI3K/AKT信号通路中相关蛋白的表达情况。结果:LncRNA RP11-79H23.3在膀胱癌组织和膀胱癌EJ细胞中表达下调(P <0.001,P<0.01),pIRES2-RP11-79H23.3转染EJ细胞结果显示,RP11-79H23.3的表达量较转染前显著增加(P<0.01)。上调RP11-79H23.3的表达可诱导膀胱癌EJ细胞的凋亡,相反,转染pIRES2-EGFP可促进EJ细胞的增殖、侵袭和迁移能力,同时,Western blot结果显示,转染pIRES2-RP11-79H23.3后可上调PTEN在EJ细胞中的表达,下调p-PI3K、p-AKT及p-Gsk3β蛋白的表达(P<0.05)。结论:LncRNA RP11-79H23.3在膀胱癌组织和膀胱癌EJ细胞中低表达(P<0.001,P<0.01),并且过表达RP11-79H23.3会降低膀胱癌细胞增殖、侵袭和迁移能力,其作用机制可能与PI3K/AKT信号通路有关。提示lncRNA RP11-79H23.3在膀胱癌恶性肿瘤中发挥重要的作用,可能会成为治疗膀胱癌的药物作用靶点。

关键词: 膀胱癌, 长链非编码RNA, RP11-79H23.3, EJ细胞

Abstract: Background and purpose: Long non-coding RNA (lncRNA) is closely associated with carcinogenesis and tumor development. However, the function of lncRNA RP11-79H23.3 has not been reported yet. Therefore, the study aimed to investigate the role of lncRNA-RP11-79H23.3 in bladder cancer cells and its mechanism. Methods: Microarray analysis was performed on 4 cases of bladder cancer and cancer adjacent tissues. The relative expression levels of RP11-79H23.3 in bladder cancer tissues, paracancerous tissues of patients, normal bladder cells sv-HUC-1 and bladder cancer cells EJ were detected by real-time fluorescence quantitative polymerase chain reaction (RTFQ-PCR). pIRES2-RP11-79H23.3 was transfected into bladder cancer EJ cells by LipofectamineTM2000. The proliferation of EJ cells was detected by cell counting kit-8 (CCK-8) and EDU. The invasion and migration ability of EJ cells were detected by transwell assays and wound healing assay respectively. Apoptosis was detected by flow cytometry, Hoechst 33342 and TUNEL assay. The localization of PTEN in bladder cancer cells was detected by immunofluorescence. The cytoskeleton formation was observed by phalloidin staining. Western blot was adopted to analyze the protein expression levels of PI3K/AKT signaling pathway in EJ cells after RP11-79H23.3 transfection. Results: The expression levels of lncRNA RP11-79H23.3 in bladder cancer tissues and bladder cancer EJ cells were significantly downregulated (P<0.001, P<0.01). pIRES2-RP11-79H23.3 was transfected into EJ cells with a high transfection efficiency. Increased expression of RP11-79H23.3 could induce apoptosis of bladder cancer EJ cells. In contrast, overexpression of pIRES2-EGFP promoted the proliferation, invasion and migration, while transfection with pIRES2-RP11-79H23.3 suppressed stress fiber formation. Evidence from Western blot showed that RP11- 79H23.3 could upregulate the expression of PTEN in EJ cells and downregulate the expression of p-PI3K, p-AKT and p-Gsk3β (P<0.05). Conclusion: The expression of lncRNA RP11-79H23.3 is significantly downregulated in bladder cancer tissues and bladder cancer EJ cells (P<0.001, P<0.01). Moreover, the proliferation, migration and invasion of bladder cancer cells are restrained after the transfection with RP11-79H23.3. LncRNA RP11-79H23.3 may be related to PI3K/AKT signaling pathway. It is indicated that lncRNA RP11-79H23.3 plays an important role in bladder cancer and may become a target for the treatment of bladder cancer.

Key words: Bladder cancer, Long non-coding RNA, RP11-79H23.3, EJ cell